But a follow-up 2021 study, known as STEP 4, showed that within 48 weeks of no longer taking semaglutide, participants regained approximately two-thirds of their prior weight loss, while those who remained on GLP-1 drug therapy continued to lose weight
SeekPeptides compiled this guide using Phase 2 and Phase 3 clinical data, pharmacokinetic research on sex-based drug clearance, and real-world titration experience
Rev Recent Clin Trials
But more rarely, they can cause: Pancreatitis Diabetic retinopathy Kidney damage Gallbladder disease Very low blood sugar Takeaways Ozempic is known as a drug that treats type 2 diabetes and helps with weight loss, but it may also improve symptoms of sleep apnea
It slows digestion and decreases appetite, which can help individuals eat less and lose weight, and stimulates the pancreas to produce more insulin when you eat, making it effective at managing blood sugar
The Phase 2 trial of retatrutide (Jastreboff et al., New England Journal of Medicine , 2023) reported that the most common adverse effects were gastrointestinal in nature (nausea, vomiting, diarrhoea), consistent with the GLP-1 receptor agonist class